Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Teich

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
BMC Gastroenterology|June 23, 2005
The presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumourNiels Teich, Jörg Kleeff, Herbert Lochs, et al.
Diabetes Care|July 29, 2006
Regression of pancreatic diabetes in chronic hereditary pancreatitisHolm H Uhlig, Angela Galler, Volker Keim, et al.
BMC Gastroenterology|April 13, 2021
Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 monthsNiels Teich, Harald Grümmer, Eric Jörgensen, et al.
Human Mutation|March 19, 2005
Gene conversion between functional trypsinogen genes PRSS1 and PRSS2 associated with chronic pancreatitis in a six-year-old girlNiels Teich, Zsófia Nemoda, Henrik Köhler, et al.
International Journal of Colorectal Disease|February 24, 2006
Ileal perforation in a patient with Crohn's disease while receiving recombinant human growth hormone therapyGernot W Wolkersdörfer, Stephan Miehlke, Ralph Schneider, et al.
World Journal of Gastroenterology|June 20, 2020
Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month resultsNiels Teich, Harald Grümmer, Eric Jörgensen, et al.
Journal of Clinical Gastroenterology|February 4, 2021
Inflammatory Bowel Disease and COVID-19: How Have Patients Coped So Far?Franziska Schlabitz, Niels Teich, Anica Riesner-Wehner, et al.
International Journal of Colorectal Disease|August 26, 2019
Predictive parameters for the clinical course of Crohn's disease: development of a simple and reliable risk modelAndreas Stallmach, Bernd Bokemeyer, Ulf Helwig, et al.
Zeitschrift Fur Gastroenterologie|January 18, 2022
SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel diseaseAhmed Elkharsawi, Ulrike von Arnim, Renate Schmelz, et al.
Inflammatory Intestinal Diseases|July 19, 2018
Cyclophosphamide Pulse Therapy in Severe Refractory Crohn's Disease: A Retrospective Multicenter Case SeriesFlorian Bär, Thomas Krause, Andreas Stallmach, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
BMC Gastroenterology|June 23, 2005
The presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumourNiels Teich, Jörg Kleeff, Herbert Lochs, et al.
Diabetes Care|July 29, 2006
Regression of pancreatic diabetes in chronic hereditary pancreatitisHolm H Uhlig, Angela Galler, Volker Keim, et al.
BMC Gastroenterology|April 13, 2021
Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 monthsNiels Teich, Harald Grümmer, Eric Jörgensen, et al.
Human Mutation|March 19, 2005
Gene conversion between functional trypsinogen genes PRSS1 and PRSS2 associated with chronic pancreatitis in a six-year-old girlNiels Teich, Zsófia Nemoda, Henrik Köhler, et al.
International Journal of Colorectal Disease|February 24, 2006
Ileal perforation in a patient with Crohn's disease while receiving recombinant human growth hormone therapyGernot W Wolkersdörfer, Stephan Miehlke, Ralph Schneider, et al.
World Journal of Gastroenterology|June 20, 2020
Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month resultsNiels Teich, Harald Grümmer, Eric Jörgensen, et al.
Journal of Clinical Gastroenterology|February 4, 2021
Inflammatory Bowel Disease and COVID-19: How Have Patients Coped So Far?Franziska Schlabitz, Niels Teich, Anica Riesner-Wehner, et al.
International Journal of Colorectal Disease|August 26, 2019
Predictive parameters for the clinical course of Crohn's disease: development of a simple and reliable risk modelAndreas Stallmach, Bernd Bokemeyer, Ulf Helwig, et al.
Zeitschrift Fur Gastroenterologie|January 18, 2022
SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel diseaseAhmed Elkharsawi, Ulrike von Arnim, Renate Schmelz, et al.
Inflammatory Intestinal Diseases|July 19, 2018
Cyclophosphamide Pulse Therapy in Severe Refractory Crohn's Disease: A Retrospective Multicenter Case SeriesFlorian Bär, Thomas Krause, Andreas Stallmach, et al.
Pageof 12